Φορτώνει......
Barriers to hepatitis C treatment in the era of direct acting antiviral agents
BACKGROUND: Direct-acting antivirals (DAA) are safe, effective treatment of hepatitis C virus (HCV). Suboptimal linkage to specialists and access to DAAs are the leading barriers to treatment; however, data are limited. AIM: Determine predictors of follow-up, receipt of DAAs, and reasons for the lac...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Aliment Pharmacol Ther |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5800315/ https://ncbi.nlm.nih.gov/pubmed/28949020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14328 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|